Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review

QR Code

Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review

Saved in:

Bibliographic Details
Main Authors:	Jacob Itkin, Sudheer Dhoop, Thomas Sodeman
Format:	Article
Language:	English
Published:	The University of Toledo 2025-06-01
Series:	Translation
Subjects:	GLP-1RAs Diabetes Gastroparesis
Online Access:	http://openjournals.utoledo.edu/index.php/translation/article/view/1363
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diabetic Gastroparesis Presenting with a Cyclic Vomiting Pattern
by: Yong Jin Nam, et al.
Published: (2017-09-01)

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
by: Giulia Migliorisi, et al.
Published: (2025-07-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

Data mining–based analysis to explore the application of an animal model of diabetic gastroparesis
by: Hui Xu, et al.
Published: (2025-07-01)

Addressing the Shortage of GLP-1 RA and Dual GIP/GLP-1 RA-Based Therapies—A Systematic Review
by: Velimir Altabas, et al.
Published: (2025-06-01)

Proposed Algorithm for the Diagnosis and Management of Diabetic Gastroparesis in the Indian Clinical Setting
by: Mohan V. G. Prasad, et al.
Published: (2025-05-01)

Features of clinical presentation, diagnostics and treatment of idiopathic gastroparesis (<i>Review of literature and case presentation</i>)
by: Yu. V. Yevsyutina, et al.
Published: (2013-07-01)

¿Combinamos AR-GLP1 + i-SGLT2? Sí o no
by: Claudia Folino
Published: (2024-10-01)

GLP-1/GLP-1R axis: from metabolism (obesity and T2DM) to immunity
by: Vijay Kumar
Published: (2025-07-01)

European Society for Neurogastroenterology and Motility Consensus on Gastroparesis: What Issues Remain Unresolved?
by: A. A. Sheptulin, et al.
Published: (2022-12-01)

Long-term tuina can inhibit the occurrence of gastroparesis by protecting gastrointestinal function in diabetic rats
by: Jian-zhen Jiang, et al.
Published: (2025-06-01)

Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus
by: Alvin Hartanto Kurniawan, et al.
Published: (2019-11-01)

Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus
by: Alvin Hartanto Kurniawan, et al.
Published: (2019-11-01)

Gastroparesis and Systemic Lupus Erythematosus: A Propensity Score‐Matched Study of US National Database Analysis
by: Noppachai Siranart, et al.
Published: (2025-07-01)

GLP-1 and Its Role in Glycogen Production: A Narrative Review
by: Joseph Lotosky, et al.
Published: (2025-06-01)

The healthcare burden imposed by children with gastroparesis and the shift imposed by COVID-19
by: Christian Sadaka, et al.
Published: (2025-07-01)

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
by: Lampros Chrysavgis, et al.
Published: (2025-06-01)

Is the Presence of a Depressive Disorder a Risk Factor for Worse Metabolic Outcomes Among Patients with Type 2 Diabetes Treated with GLP-1 Analogs?
by: Joana Nicolau, et al.
Published: (2025-07-01)

Genetic analysis of the correlation between GLP1 action and metabolic liver disease: Insights from Mendelian randomization analysis
by: Zhiqiang Ma, et al.
Published: (2025-08-01)

Prescribing Antidiabetic Medications Among GPs in Croatia—A Real-Life Cross-Sectional Study
by: Tomislav Kurevija, et al.
Published: (2025-06-01)

The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes
by: Alan Sinclair, et al.
Published: (2025-06-01)

Individualized virtual integrative medicine (IVIM): A clinical model for enhanced GLP-1 therapeutic outcomes
by: Jessica Duncan, et al.
Published: (2025-09-01)

Clinical manifestations of gastroparesis, masking low colic obstruction (<i>Diagnostic capabilities options of transabdominal ultrasound investigation</i>)
by: Z. A. Lemeshko, et al.
Published: (2009-08-01)

Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP‐1 Receptor Agonists: A Systematic Review and Meta‐Analysis
by: Maheen Asif, et al.
Published: (2025-07-01)

Hormonal modulation, mitochondria and Alzheimer’s prevention: the role of GLP-1 agonists and estrogens
by: Fernando Lizcano, et al.
Published: (2025-06-01)

Effect of GLP-1 Receptor Agonists (Liraglutide) on Glycemic Parameters and Circulating miRNA Expression in Type 2 Diabetes Mellitus
by: Aqeel Meer AL-ZAMILY
Published: (2025-06-01)

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists
by: Haoran Jiang, et al.
Published: (2025-08-01)

The Impact and Safety of GLP‐1 Agents and Breast Cancer
by: Kayla Parsons, et al.
Published: (2025-06-01)

Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment
by: Łukasz Zdziebkowski, et al.
Published: (2025-07-01)

Liraglutide Attenuates Atorvastatin-Induced Hepatotoxicity by Restoring GLP-1R Expression and Activating Nrf2 and Autophagy Pathways in Wistar Rats
by: Engy A. Elsiad, et al.
Published: (2025-07-01)

Study of antitumor effectiveness of Ras GTPase peptide inhibitor (Inh-Ras) in xenograft model of non-small cell lung cancer
by: T. M. Kulinich, et al.
Published: (2025-04-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
by: T. V. Saprina, et al.
Published: (2013-06-01)

Intra-pyloric botulinum toxin injection improves liquid gastric emptying using 99mTc DTPA scintigraphy: a case report in a 2 years- old girl with idiopathic gastroparesis
by: Khadijah Sumitro, et al.
Published: (2025-07-01)

Training-specific effects on metabolic-inflammatory mediators: GLP-1 and Dectin-1 changes following resistance, continuous, or interval exercise in overweight women
by: Leila Nouri Ain, et al.
Published: (2025-03-01)

A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH)
by: Zhipeng Zhang, et al.
Published: (2025-04-01)

Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)
by: Daisuke Tsuriya, et al.
Published: (2025-07-01)

Glucagon-like Peptide-1 Receptor Agonists: A New Frontier in Treating Alcohol Use Disorder
by: Tyler S. Oesterle, et al.
Published: (2025-06-01)

Innovations in Pharmacotherapy of Diabetes: A Review of Latest Reports
by: Katarzyna Czechowska, et al.
Published: (2025-07-01)

Physiology and pharmacology of glucagon-like peptide-1 receptor
by: D. V. Kurkin, et al.
Published: (2024-01-01)

Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice
by: Gašper Tonin, et al.
Published: (2025-07-01)